US › Healthcare

Telomir Pharmaceuticals, Inc. Common Stock (TELO)

US · Healthcare · Biotechnology

$0.71-8.97%

Last close · 2026-11-06

Latest quarter · ended 2026-06-30

Revenue

Net profit

$-1.7M

EPS

$-0.79

Key statistics

Market cap

$57.5M

Forward P/E

0.0

P/B

13.32

Book value

$0.07

EPS (TTM)

$-1.01

52-week high

$1.58

52-week low

$0.69

50-day MA

$1.11

200-day MA

$1.22

Beta

-0.19

Analyst view

Analysts rate Telomir Pharmaceuticals, Inc. Common Stock a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $4.00.

Shareholding

Insiders

42.98%

Institutions

4.01%

Largest institutional holders

Fund	Stake
Vanguard Capital Management, LLC	2.19%
Geode Capital Management, LLC	0.46%
BlackRock Inc	0.38%
Vanguard Fiduciary Trust Co	0.31%
Northern Trust Corp	0.08%
State Street Corp	0.08%
Bank of New York Mellon Corp	0.07%
CapTrust Financial Advisors	0.07%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Telomir Pharmaceuticals, Inc. Common Stock — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-11-07.